Lung cancer Posts - Page 42 of 52 on Medivizor
Navigation Menu

Lung cancer Posts on Medivizor

Comparison of different surgical procedures in stage I non-small cell lung cancer

Comparison of different surgical procedures in stage I non-small cell lung cancer

Posted by on Apr 30, 2015 in Lung cancer | 0 comments

In a nutshell The authors aimed to analyze the effect of different surgical procedures on survival of stage I non-small cell lung cancer (NSCLC) patients. Some background NSCLC is the most common type of lung cancer. In stage I (early stage) NSCLC, surgery is the treatment of choice. There are three main surgical procedures that could be performed...

Read More

Challenges and treatment options for EGFR-mutant non-small cell lung cancer patients

Challenges and treatment options for EGFR-mutant non-small cell lung cancer patients

Posted by on Apr 28, 2015 in Lung cancer | 0 comments

In a nutshell In this review, the authors summarized different treatment strategies based on clinical trial findings in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) patients. Some background NSCLC is the most common type of lung cancer. In advanced NSCLC patients, the EGFR gene (produces proteins involved...

Read More

Burden of Bills: Living With Cancer in the US

Burden of Bills: Living With Cancer in the US

Posted by on Apr 24, 2015 in Blog, Breast cancer, Colorectal cancer, Lung cancer, Lymphoma, Melanoma, Prostate cancer |

“I also know that the sooner I die, the more money my family will have.” ~from the post Why Advocate? by Lori Marx-Rubiner On hearing the word “cancer” from your physician, your first thoughts are naturally on treatment. In fact, your focus should be on treatment. Unfortunately and sometimes tragically, in the US finances need to be a top...

Read More

Immune cell therapy in non-small cell lung cancer

Posted by on Apr 16, 2015 in Lung cancer | 0 comments

In a nutshell The authors aimed to determine the effect of cytokine-induced killer cells for treatment of non-small cell lung cancer.  Some background Cytokine-induced killer cells (CIK) are man-made immune cells (fight infection and disease) that can recognize infected or cancerous cells in the absence of other immune cells, which allows for...

Read More

Non-small cell lung cancer – no survival benefit between two types of surgery

Posted by on Apr 7, 2015 in Lung cancer | 0 comments

In a nutshell This study compared the long-term outcome for non-small cell lung cancer patients who underwent video-assisted surgery and those who underwent open lung surgery. Some background Video-assisted thoracoscopic surgery (VATS) involves making cuts in the chest wall and placing a scope specifically designed to view the lungs through...

Read More

Dalotuzumab in extensive-stage small-cell lung cancer

Dalotuzumab in extensive-stage small-cell lung cancer

Posted by on Mar 30, 2015 in Lung cancer | 0 comments

In a nutshell The authors aimed to determine the effects of dalotuzumab in treating small-cell lung cancer when combined with cisplatin and etoposide. Some background Extensive-stage small-cell lung cancer (SCLC – cancer has spread outside of the chest) represents 15% of all lung cancer cases. Though numerous treatments have been used over...

Read More

High YAP protein levels indicate improved treatment response in lung cancer patients

High YAP protein levels indicate improved treatment response in lung cancer patients

Posted by on Mar 16, 2015 in Lung cancer | 0 comments

In a nutshell The authors aimed to determine whether levels of YAP protein could predict the success of treatment in patients with lung cancer. Some background YAP protein is a protein active in many cancers that can have a positive or negative effect depending on the location. When YAP protein is present in the nucleus (brain of the cancer...

Read More